Adaptable Intranasal Pain Relief Systems for Niche Environments

Publication ID: 24-11857520_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptable Intranasal Pain Relief Systems for Niche Environments,” Published Technical Disclosure No. 24-11857520_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857520_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,520.

Summary of the Inventive Concept

A family of portable, preservative-free intranasal composition spray systems designed for specific, high-need markets, such as disaster relief, high-security, emergency response, remote areas, and extreme weather conditions.

Background and Problem Solved

The original patent disclosed a preservative-free intranasal composition for treating various pain conditions. However, the original formulation and device were not adapted for use in extreme or specialized environments. This inventive concept addresses the need for adaptable, reliable, and effective pain relief solutions in niche markets.

Detailed Description of the Inventive Concept

The new inventive concept comprises a range of systems, each tailored to a specific operational environment. For disaster relief, a portable, lightweight spray container is designed for easy transport and use in extreme weather conditions. For high-security needs, a secure, tamper-evident spray device ensures the composition is administered safely and securely. For emergency response situations, a handheld intranasal spray device with a mechanical pump is optimized for high-stress environments. For remote, hard-to-reach areas, a solar-powered mechanical pump device enables reliable operation. Finally, for extreme cold weather conditions, a thermally-insulated spray device maintains the composition's efficacy.

Novelty and Inventive Step

The new claims introduce novel adaptations of the original preservative-free intranasal composition for specific, high-need markets. The inventive step lies in the tailored design of each system to address the unique challenges and constraints of its respective operational environment.

Alternative Embodiments and Variations

Alternative embodiments may include variations in spray container materials, mechanical pump designs, or thermally-insulated devices. Additional variations could include integration with wearable devices or telemedicine platforms to enhance patient monitoring and treatment.

Potential Commercial Applications and Market

The adaptable intranasal pain relief systems have significant commercial potential in various industries, including disaster relief, high-security, emergency response, remote healthcare, and extreme weather operations. The market demand for effective, reliable, and specialized pain relief solutions in these niches is substantial, and this inventive concept is well-positioned to capitalize on these opportunities.

CPC Classifications

SectionClassGroup
A A61 A61K31/167
A A61 A61K9/0043
A A61 A61M11/00
A A61 A61M2210/0618

Original Patent Information

Patent NumberUS 11,857,520
TitleTherapeutic composition of intranasal lidocaine
Assignee(s)Nortic Holdings Inc.